D. Spielmann
About
D. Spielmann is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Nutrition and Dietetics.
According to data from OpenAlex, D. Spielmann has authored 22 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Genetics and 7 papers in Nutrition and Dietetics. Recurrent topics in D. Spielmann's work include Estrogen and related hormone effects (9 papers), Menopause: Health Impacts and Treatments (8 papers) and Fatty Acid Research and Health (7 papers). D. Spielmann is often cited by papers focused on Estrogen and related hormone effects (9 papers), Menopause: Health Impacts and Treatments (8 papers) and Fatty Acid Research and Health (7 papers). D. Spielmann collaborates with scholars based in France, United States and Italy. D. Spielmann's co-authors include F. Mendy, B Jacotot, Helmut Traitler, Ginger D. Constantine, Gary S. Grubb, Howard Sprecher, Michel Guichardant, Paul‐André Finot, A. Teíchmann and R. T. Holman and has published in prestigious journals such as Obstetrics and Gynecology, Pharmacology Biochemistry and Behavior and Journal of Parenteral and Enteral Nutrition.
In The Last Decade
D. Spielmann
22 papers receiving 379 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| D. Spielmann France | 13 | 185 | 125 | 94 | 81 | 66 | 22 | 406 | ||
| F M Sacks United States | 8 | 119 0.6× | 164 1.3× | 108 1.1× | 77 1.0× | 18 0.3× | 11 | 359 | ||
| Nargis A. Alam United States | 8 | 195 1.1× | 152 1.2× | 84 0.9× | 131 1.6× | 85 1.3× | 11 | 575 | ||
| B Gullberg Sweden | 7 | 107 0.6× | 91 0.7× | 240 2.6× | 111 1.4× | 25 0.4× | 8 | 466 | ||
| DP Rose United Kingdom | 9 | 97 0.5× | 39 0.3× | 155 1.6× | 58 0.7× | 27 0.4× | 11 | 504 | ||
| Geraldine Skurnik United States | 8 | 219 1.2× | 74 0.6× | 90 1.0× | 16 0.2× | 19 0.3× | 13 | 533 | ||
| Monique J.M. de Groot Netherlands | 12 | 61 0.3× | 104 0.8× | 49 0.5× | 13 0.2× | 30 0.5× | 21 | 366 | ||
| GM Wardlaw United States | 8 | 254 1.4× | 77 0.6× | 151 1.6× | 33 0.4× | 7 0.1× | 8 | 625 | ||
| Eugène Jansen Netherlands | 9 | 139 0.8× | 61 0.5× | 36 0.4× | 28 0.3× | 12 0.2× | 13 | 402 | ||
| Constanze C. Maresch Germany | 7 | 72 0.4× | 100 0.8× | 75 0.8× | 58 0.7× | 158 2.4× | 8 | 483 | ||
| Jolene McMonagle Ireland | 11 | 187 1.0× | 98 0.8× | 138 1.5× | 54 0.7× | 5 0.1× | 14 | 543 |
Countries citing papers authored by D. Spielmann
Since
Specialization
Citations
This map shows the geographic impact of D. Spielmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Spielmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Spielmann more than expected).
Fields of papers citing papers by D. Spielmann
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by D. Spielmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Spielmann. The network helps show where D. Spielmann may publish in the future.
Co-authorship network of co-authors of D. Spielmann
This figure shows the co-authorship network connecting the top 25 collaborators of D. Spielmann. A scholar is included among the top collaborators of D. Spielmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Spielmann. D. Spielmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Teíchmann, A., Dan Apter, Janusz Emerich, et al.. (2009). Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial. Contraception. 80(6). 504–511.
2.
Teíchmann, A., et al.. (2006). Comparative Trial of Continuous-Use and 21-Day Cyclic Levonorgestrel and Ethinyl Estradiol Oral Contraceptive. Obstetrics and Gynecology. 107(Supplement). 12S–12S.
3.
Bouchard, P, et al.. (2005). Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17 beta -estradiol/trimegestone versus 1 or 2 mg 17 beta -estradiol/norethisterone acetate in postmenopausal women. Gynecological Endocrinology. 21(3). 142–148.
4.
Koninckx, PR, et al.. (2005). A comparative 2-year study of the effects of sequential regimens of 1 mg 17β-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women. Gynecological Endocrinology. 21(2). 82–89.
5.
Gambacciani, Marco, et al.. (2005). Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17β-estradiol and trimegestone versus two regimens containing 1 or 2 mg 17β-estradiol and norethisterone acetate. Gynecological Endocrinology. 21(2). 65–73.
6.
Grubb, Gary S., D. Spielmann, James H. Pickar, & Ginger D. Constantine. (2003). Clinical experience with trimegestone as a new progestin in HRT. Steroids. 68(10-13). 921–926.
7.
Tuimala, Risto, N. Siseles, H. S. Goei Thè, et al.. (2002). Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone. Gynecological Endocrinology. 16(2). 155–162.
8.
Fernández-Murga, María Leonor, et al.. (2001). A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone. Gynecological Endocrinology. 15(5). 349–358.
9.
Tuimala, Risto, et al.. (2001). A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone. Gynecological Endocrinology. 15(5). 349–358.
10.
Mooren, Marius J. van der, et al.. (1999). A comparative study of the effects of gestodene 60 µg/ethinylestradiol 15 µg and desogestrel 150 µg/ethinylestradiol 20 µg on hemostatic balance, blood lipid levels and carbohydrate metabolism. The European Journal of Contraception & Reproductive Health Care. 4(sup2). 27–35.
11.
Coenen, C, J.M.G. Hollanders, Rosalind M. Rolland, D. Spielmann, & Johan Bulten. (1996). The effects of a low-dose gestodene-containing oral contraceptive on endometrial histology in healthy women. The European Journal of Contraception & Reproductive Health Care. 1(4). 325–329.
12.
Spielmann, D. & F. Mendy. (1993). Nomenclature, synthèse et métabolisme des acides gras insaturés. Nutrition Clinique et Métabolisme. 7(1). 3–18.
13.
Guichardant, Michel, Helmut Traitler, D. Spielmann, Howard Sprecher, & Paul‐André Finot. (1993). Stearidonic acid, an inhibitor of the 5‐lipoxygenase pathway. A comparison with timnodonic and dihomogammalinolenic acid. Lipids. 28(4). 321–324.
14.
Férard, G, Yves Ingenbleek, Michel Hasselmann, et al.. (1992). Composition of Phospholipid Fatty Acids in Red Blood Cell Membranes of Patients in Intensive Care Units: Effects of Different Intakes of Soybean Oil, Medium‐Chain Triglycerides, and Black‐Currant Seed Oil. Journal of Parenteral and Enteral Nutrition. 16(2). 136–141.
15.
Spielmann, D., U. Bracco, Helmut Traitler, et al.. (1988). Alternative Lipids to Usual ω6 PUFAS: γ‐Linolenic Acid, α‐Linolenic Acid, Stearidonic Acid, EPA, Etc. Journal of Parenteral and Enteral Nutrition. 12(6S). 111S–123S.
16.
Rizkalla, Salwa W., F. Baigts, Frédéric Fumeron, et al.. (1986). Comparative effects of several simple carbohydrates on erythrocyte insulin receptors in obese subjects. Pharmacology Biochemistry and Behavior. 25(3). 681–688.
17.
Mendy, F., et al.. (1985). Effects of different dietary intake of essential fatty acids on C20∶3ω6 and C20∶4ω6 serum levels in human adults. Lipids. 20(4). 227–233.
18.
Orsetti, A, et al.. (1984). Effects of dietary gamma-linolenate supplementation on serum lipids and platelet function in insulin-dependent diabetic patients.. PubMed. 38(2). 121–30.
19.
Mendy, F., et al.. (1983). [Rediscovery of an oleaginous plant: Oenothera biennis. The importance of gamma-linolenic acid in nutrition].. PubMed. 167(8). 923–31.
20.
Spielmann, D., et al.. (1981). [Comparative desaturation of linoleic and dihomo-gamma-linolenic acids by homogenates of human liver in vitro].. PubMed. 292(16). 911–4.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by F M Sacks Breakdown of academic impact, for papers by Nargis A. Alam Breakdown of academic impact, for papers by B Gullberg Breakdown of academic impact, for papers by DP Rose Breakdown of academic impact, for papers by Geraldine Skurnik Breakdown of academic impact, for papers by Monique J.M. de Groot Breakdown of academic impact, for papers by GM Wardlaw Breakdown of academic impact, for papers by Eugène Jansen Breakdown of academic impact, for papers by Constanze C. Maresch Breakdown of academic impact, for papers by Jolene McMonagle